| Dr Emily L Sammons, MD | |
|
1000 Edgewater Pointe, Suite 200, Lake St Louis, MO 63367 | |
| (636) 561-8088 | |
| (636) 561-1405 |
| Full Name | Dr Emily L Sammons |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1000 Edgewater Pointe, Lake St Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780860395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 01064812A (Indiana) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 2010014125 (Missouri) | Primary |
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
"Two Republican congressmen who help oversee billions of dollars for people with AIDS are asking the federal government for an accounting of fraud and mismanagement complaints leveled against AIDS programs nationwide," The Washington Post reports.
High glucose in obesity appears to gum up the works of the circadian clocks inside our cells that help regulate the timing of many body functions across the 24-hour day and drive the risk of cardiovascular disease, scientists say.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
› Verified 1 days ago
| Entity Name | Heartland Women's Healthcare Mo Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588191431 PECOS PAC ID: 7618236415 Enrollment ID: O20180124003159 |
News Archive
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
"Two Republican congressmen who help oversee billions of dollars for people with AIDS are asking the federal government for an accounting of fraud and mismanagement complaints leveled against AIDS programs nationwide," The Washington Post reports.
High glucose in obesity appears to gum up the works of the circadian clocks inside our cells that help regulate the timing of many body functions across the 24-hour day and drive the risk of cardiovascular disease, scientists say.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily L Sammons, MD 1000 Edgewater Pointe, Suite 200, Lake St Louis, MO 63367 Ph: (636) 561-8088 | Dr Emily L Sammons, MD 1000 Edgewater Pointe, Suite 200, Lake St Louis, MO 63367 Ph: (636) 561-8088 |
News Archive
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
"Two Republican congressmen who help oversee billions of dollars for people with AIDS are asking the federal government for an accounting of fraud and mismanagement complaints leveled against AIDS programs nationwide," The Washington Post reports.
High glucose in obesity appears to gum up the works of the circadian clocks inside our cells that help regulate the timing of many body functions across the 24-hour day and drive the risk of cardiovascular disease, scientists say.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
› Verified 1 days ago
Brian Allen Andrews, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 Medical Plz, Ste 221, Lake St Louis, MO 63367 Phone: 636-561-2229 Fax: 636-625-5288 | |
Dr. Shayla S Rose, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 300 Medical Plz, Lake St Louis, MO 63367 Phone: 636-625-2662 Fax: 636-669-2401 | |
Frank Delbert Moeller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 Medical Plaza, Suite 200, Lake St Louis, MO 63367 Phone: 636-561-8088 Fax: 636-561-1405 | |
Dr. Karyn L. Fowler, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 300 Medical Plz, Lake St Louis, MO 63367 Phone: 636-625-2662 Fax: 636-669-2401 |